CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Inspiratory muscle training +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02270333
NCT02270333N/ACompleted

Effects of Inspiratory Muscle Training in Patients With Sarcoidosis

Gazi University·interventional·Posted Oct 21, 2014·Updated Oct 21, 2014

In Brief

A clinical study evaluating Inspiratory muscle training and Sham inspiratory muscle training for Sarcoidosis. Completed, enrolled 30 participants.

Detailed Summary

Respiratory muscle weakness results with decreased exercise capacity, worse fatigue, dyspnea and quality of life in patients with sarcoidosis. However, no study investigated the effects of inspiratory muscle training (IMT), therefore effects of IMT on outcomes in patients with sarcoidosis were investigated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSarcoidosis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 21, 2014
Enrollment StartApr 1, 2012
Primary CompletionSep 1, 2013
Study CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 11.7 years ago

Interventions

Inspiratory muscle trainingdevice

Treatment group received inspiratory muscle training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 40% of maximal inspiratory pressure (MIP). The MIP was measured at supervised session each week, and 40% of measured MIP value was the new training workload. The treatment group trained for 30 min-per/day, 7 days/week, for 6 weeks. Six sessions at home and 1 session were performed at department.

Sham inspiratory muscle trainingdevice

Control group received sham inspiratory muscle training (IMT) at fixed workload, 5% of MIP using threshold loading device (POWERbreathe Classic device IMT Technologies Ltd. Birmingham, England). The control group trained for 30 min-per/day, 7 days/week, for 6 weeks. Six sessions at home and 1 session were performed at department.